Pandion Therapeutics, Inc. (NASDAQ: PAND), a clinical-stage biotechnology company developing modular biologics for autoimmune regulation, has entered into a definitive agreement with Merck (NYSE: MRK) to be acquired for $60 per share in cash, for an approximate total equity value of $1.85 billion. The acquisition...
Celsion Corporation (NASDAQ: CLSN) announced the receipt of a Fast-Track Designation from the U.S. Food and Drug Administration (FDA) for GEN-1, its DNA-mediated interleukin-12 (IL-12) immunotherapy that is currently undergoing Phase II trials for the treatment of advanced ovarian cancer. The candidate is an IL-12...
Cassava Sciences, Inc. (NASDAQ: SAVA), a clinical-stage company, announced that it has reached a consensus with the U.S. Food and Drug Administration (FDA), as to key elements of a crucial Phase 3 clinical program for Simufilam, its lead candidate for the treatment of Alzheimer’s. The...
T2 Biosystems, Inc. recently announced that its T2SARS-CoV-2™ Panel, a molecular diagnostic test that detects SARS-CoV-2, can detect the Brazil (P.1) variant of the SARS-CoV-2 virus. This expands the utility of its panel to reliably detect newer variants that have emerged in United Kingdom (B.1.1.7)...
IZEA Worldwide, Inc. (NASDAQ: IZEA), a premier marketing technology Company, announced that it has been awarded expansion of a military contract, that was originally signed in November 2020. The mid-six figure contract was the largest ever received by the company from a federal agency, and...
The Global Electric Vehicle Charging Market is poised to reach USD 63.9 billion by 2025, growing at a CAGR of 32.6 percent, according to a report by Grand View Research, Inc. The growth of this industry is a result of the initiatives by governments around the...
Atossa Therapeutics, Inc. (NASDAQ: ATOS), formerly known as Atossa Genetics, develops medical devices, laboratory tests and therapeutics to address issues in breast health. However, the Company has jumped on to the COVID-19 drug development bandwagon with its AT-H201, an inhalation therapy and AT-301, a nasal...
Sesen Bio, Inc. (NASDAQ: SESN) is focused on creating targeted fusion protein therapeutics (TFPTs) for treatment of cancers. The Company is looking at a major catalyst in 2021, the approval of Vicineum, a potential best-in-class therapeutic for the treatment of non-muscle invasive bladder cancer (NMIBC)...
Aviat Networks, Inc. (NASDAQ: AVNW), a provider of wireless networking products and solutions, has been selected by DISH Network Corporation (NASDAQ: DISH), owner of the direct-broadcast satellite provider Dish, and IPTV service Sling TV, as a supplier of 5G microwave transport for its 5G business....
CalAmp Corp (NASDAQ: CAMP), a pioneering telematics solutions provider for the connected economy, announced the adoption of its award-winning “Here Comes the Bus” School Bus Tracking technology by The Atlanta Public Schools (APS), that serves nearly 51,000 students across 87 schools and five programs. The...
